Search Results - "BMC infectious diseases"

Refine Results
  1. 1

    Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients by Dessie, Zelalem G, Zewotir, Temesgen

    Published in BMC infectious diseases (21-08-2021)
    “…Abstract Background Mortality rates of coronavirus disease-2019 (COVID-19) continue to rise across the world. The impact of several risk factors on coronavirus…”
    Get full text
    Journal Article
  2. 2

    Recognition of aerosol transmission of infectious agents: a commentary by Tellier, Raymond, Li, Yuguo, Cowling, Benjamin J, Tang, Julian W

    Published in BMC infectious diseases (31-01-2019)
    “…Although short-range large-droplet transmission is possible for most respiratory infectious agents, deciding on whether the same agent is also airborne has a…”
    Get full text
    Journal Article
  3. 3

    Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU by Sharifipour, Ehsan, Shams, Saeed, Esmkhani, Mohammad, Khodadadi, Javad, Fotouhi-Ardakani, Reza, Koohpaei, Alireza, Doosti, Zahra, Ej Golzari, Samad

    Published in BMC infectious diseases (01-09-2020)
    “…COVID-19 is known as a new viral infection. Viral-bacterial co-infections are one of the biggest medical concerns, resulting in increased mortality rates. To…”
    Get full text
    Journal Article
  4. 4

    SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis by Ssentongo, Paddy, Ssentongo, Anna E, Voleti, Navya, Groff, Destin, Sun, Ashley, Ba, Djibril M, Nunez, Jonathan, Parent, Leslie J, Chinchilli, Vernon M, Paules, Catharine I

    Published in BMC infectious diseases (07-05-2022)
    “…The temporal evolution of SARS-CoV-2 vaccine efficacy and effectiveness (VE) against infection, symptomatic, and severe COVID-19 is incompletely defined. The…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Predictors of willingness to get a COVID-19 vaccine in the U.S by Kelly, Bridget J, Southwell, Brian G, McCormack, Lauren A, Bann, Carla M, MacDonald, Pia D M, Frasier, Alicia M, Bevc, Christine A, Brewer, Noel T, Squiers, Linda B

    Published in BMC infectious diseases (12-04-2021)
    “…As COVID-19 vaccine distribution efforts continue, public health workers can strategize about vaccine promotion in an effort to increase willingness among…”
    Get full text
    Journal Article
  7. 7

    Antimicrobial resistance in Africa: a systematic review by Tadesse, Birkneh Tilahun, Ashley, Elizabeth A, Ongarello, Stefano, Havumaki, Joshua, Wijegoonewardena, Miranga, González, Iveth J, Dittrich, Sabine

    Published in BMC infectious diseases (11-09-2017)
    “…Antimicrobial resistance (AMR) is widely acknowledged as a global problem, yet in many parts of the world its magnitude is still not well understood. This…”
    Get full text
    Journal Article
  8. 8

    The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09 by MacIntyre, Chandini Raina, Chughtai, Abrar Ahmad, Barnes, Michelle, Ridda, Iman, Seale, Holly, Toms, Renin, Heywood, Anita

    Published in BMC infectious diseases (07-12-2018)
    “…The aim of this study was to estimate the prevalence of pneumonia and secondary bacterial infections during the pandemic of influenza A(H1N1)pdm09. A…”
    Get full text
    Journal Article
  9. 9

    Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study by Gong, Jing, Dong, Hui, Xia, Qing-Song, Huang, Zhao-Yi, Wang, Ding-Kun, Zhao, Yan, Liu, Wen-Hua, Tu, Sheng-Hao, Zhang, Ming-Min, Wang, Qi, Lu, Fu-Er

    Published in BMC infectious diseases (21-12-2020)
    “…COVID-19 is highly contagious, and the crude mortality rate could reach 49% in critical patients. Inflammation concerns on disease progression. This study…”
    Get full text
    Journal Article
  10. 10

    COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection by Escandón, Kevin, Rasmussen, Angela L, Bogoch, Isaac I, Murray, Eleanor J, Escandón, Karina, Popescu, Saskia V, Kindrachuk, Jason

    Published in BMC infectious diseases (27-07-2021)
    “…Scientists across disciplines, policymakers, and journalists have voiced frustration at the unprecedented polarization and misinformation around coronavirus…”
    Get full text
    Journal Article
  11. 11

    Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study by Zhao, Xin-Ying, Xu, Xuan-Xuan, Yin, Hai-Sen, Hu, Qin-Ming, Xiong, Tao, Tang, Yuan-Yan, Yang, Ai-Ying, Yu, Bao-Ping, Huang, Zhi-Ping

    Published in BMC infectious diseases (29-04-2020)
    “…Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of…”
    Get full text
    Journal Article
  12. 12

    Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis by Shi, Changcheng, Wang, Limin, Ye, Jian, Gu, Zhichun, Wang, Shuying, Xia, Junbo, Xie, Yaping, Li, Qingyu, Xu, Renjie, Lin, Nengming

    Published in BMC infectious diseases (08-07-2021)
    “…Abstract Background Coronavirus disease 2019 (COVID-19) is associated with a high mortality rate, especially in patients with severe illness. We conducted a…”
    Get full text
    Journal Article
  13. 13

    Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions by Song, Juhyun, Park, Dae Won, Moon, Sungwoo, Cho, Han-Jin, Park, Jong Hak, Seok, Hyeri, Choi, Won Seok

    Published in BMC infectious diseases (12-11-2019)
    “…This study investigated the clinical value of interleukin-6 (IL-6), pentraxin 3 (PTX3), and procalcitonin (PCT) in patients with sepsis and septic shock…”
    Get full text
    Journal Article
  14. 14

    Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial by Nojomi, Marzieh, Yassin, Zeynab, Keyvani, Hossein, Makiani, Mahin Jamshidi, Roham, Maryam, Laali, Azadeh, Dehghan, Nasir, Navaei, Mehrnaz, Ranjbar, Mitra

    Published in BMC infectious diseases (14-12-2020)
    “…Treatment of patients with COVID-19 has included supportive care to mainly relief symptoms of the disease. Although World Health Organization (WHO) has not…”
    Get full text
    Journal Article
  15. 15

    The prevalence of HIV among MSM in China: a large-scale systematic analysis by Dong, Meng-Jie, Peng, Bin, Liu, Zhen-Feng, Ye, Qian-Ni, Liu, Hao, Lu, Xi-Li, Zhang, Bo, Chen, Jia-Jia

    Published in BMC infectious diseases (27-11-2019)
    “…The prevalence of HIV among men who have sex with men (MSM) has become a significant public health challenge. The aim was to comprehensively estimate the…”
    Get full text
    Journal Article
  16. 16

    Hepatitis B infection in the general population of China: a systematic review and meta-analysis by Wang, Huai, Men, Peixuan, Xiao, Yufeng, Gao, Pei, Lv, Min, Yuan, Qianli, Chen, Weixin, Bai, Shuang, Wu, Jiang

    Published in BMC infectious diseases (18-09-2019)
    “…Abstract Background Hepatitis B virus (HBV) infection is a major public health problem in China. Over a decade has passed since the last National Hepatitis…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Effective inhibition of MERS-CoV infection by resveratrol by Lin, Shih-Chao, Ho, Chi-Tang, Chuo, Wen-Ho, Li, Shiming, Wang, Tony T, Lin, Chi-Chen

    Published in BMC infectious diseases (13-02-2017)
    “…Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging viral pathogen that causes severe morbidity and mortality. Up to date, there is no…”
    Get full text
    Journal Article
  19. 19

    A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance by Bell, Brian G, Schellevis, Francois, Stobberingh, Ellen, Goossens, Herman, Pringle, Mike

    Published in BMC infectious diseases (09-01-2014)
    “…Greater use of antibiotics during the past 50 years has exerted selective pressure on susceptible bacteria and may have favoured the survival of resistant…”
    Get full text
    Journal Article
  20. 20

    Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine by Seale, Holly, Heywood, Anita E, Leask, Julie, Sheel, Meru, Durrheim, David N, Bolsewicz, Katarzyna, Kaur, Rajneesh

    Published in BMC infectious diseases (28-01-2021)
    “…As immunisation program launches have previously demonstrated, it is essential that careful planning occurs now to ensure the readiness of the public for a…”
    Get full text
    Journal Article